"Virulence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
| Descriptor ID |
D014774
|
| MeSH Number(s) |
G06.930
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Virulence".
Below are MeSH descriptors whose meaning is more specific than "Virulence".
This graph shows the total number of publications written about "Virulence" by people in this website by year, and whether "Virulence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 8 | 8 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 4 | 4 |
| 2005 | 1 | 11 | 12 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 5 | 5 |
| 2011 | 0 | 10 | 10 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 11 | 11 |
| 2015 | 0 | 11 | 11 |
| 2016 | 0 | 9 | 9 |
| 2017 | 14 | 92 | 106 |
| 2018 | 11 | 91 | 102 |
| 2019 | 1 | 34 | 35 |
| 2020 | 3 | 40 | 43 |
| 2021 | 2 | 24 | 26 |
To return to the timeline, click here.
Below are the most recent publications written about "Virulence" by people in Profiles.
-
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. mBio. 2021 08 31; 12(4):e0141521.
-
Evolving threat. Science. 2021 Aug 20; 373(6557):844-849.
-
Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs. Infect Immun. 2021 08 16; 89(9):e0018821.
-
Hijacking of the Host's Immune Surveillance Radars by Burkholderia pseudomallei. Front Immunol. 2021; 12:718719.
-
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021 08 10; 54(8):1853-1868.e7.
-
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. J Virol. 2021 07 26; 95(16):e0061721.
-
SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs. J Evol Biol. 2021 12; 34(12):1867-1877.
-
Updated SARS-CoV-2 single nucleotide variants and mortality association. J Med Virol. 2021 12; 93(12):6525-6534.
-
Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity. Chembiochem. 2021 08 17; 22(16):2641-2649.
-
Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. PLoS Pathog. 2021 07; 17(7):e1009381.